Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
European Heart Journal|June 19, 2018
Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trialDirk Sibbing, Lisa Gross, Dietmar Trenk, et al.
Circulation. Cardiovascular Interventions|May 24, 2012
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trialDominick J Angiolillo, Robert C Welsh, Dietmar Trenk, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
European Heart Journal|January 30, 2020
Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromesRobert F Storey, Paul A Gurbel, Jurrien Ten Berg, et al.
European Heart Journal|June 22, 2019
Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trialDániel Aradi, Lisa Gross, Dietmar Trenk, et al.
Journal of the American College of Cardiology|September 11, 2010
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphateLaurent Bonello, Udaya S Tantry, Rossella Marcucci, et al.
JAMA|October 28, 2010
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysisJessica L Mega, Tabassome Simon, Jean-Philippe Collet, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 2, 2021
Determinants of fibrotic atrial cardiomyopathy in atrial fibrillation. A multicenter observational study of the RETAC (reseau européen de traîtement d'arrhythmies cardiaques)-groupBjörn Müller-Edenborn, Zoraida Moreno-Weidmann, Sandrine Venier, et al.
JACC. Cardiovascular Interventions|September 22, 2022
Apixaban and Valve Thrombosis After Transcatheter Aortic Valve Replacement: The ATLANTIS-4D-CT Randomized Clinical Trial SubstudyGilles Montalescot, Alban Redheuil, Flavien Vincent, et al.
Lancet (London, England)|September 1, 2017
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trialDirk Sibbing, Dániel Aradi, Claudius Jacobshagen, et al.
Pageof 12